Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Procizumab by 4TEEN4 Pharmaceuticals for Cardiogenic Shock: Likelihood of Approval
Procizumab is under clinical development by 4TEEN4 Pharmaceuticals and currently in Phase I for Cardiogenic Shock. According to GlobalData, Phase...
Data Insights
Procizumab by 4TEEN4 Pharmaceuticals for Acute Heart Failure: Likelihood of Approval
Procizumab is under clinical development by 4TEEN4 Pharmaceuticals and currently in Phase I for Acute Heart Failure. According to GlobalData,...